Medical Facility News

CHRISTUS Surgery Center–Olympia Hills Celebrates Grand Opening Event

CHRISTUS Surgery Center-Olympia Hills opened its doors to the community during a special grand opening for the premier outpatient facility now serving San Antonio’s growing northeast side.

CHRISTUS Health associates, community leaders and church officials cut the ribbon on the...


World-Class Urologic Oncology Care for South Texas at CHRISTUS Santa Rosa Health System

In just two years, CHRISTUS Santa Rosa Health System has assembled a team of nearly 40 urologic oncologists and other specialists from across San Antonio that focuses on diagnosing, treating and preventing urologic cancers in south Texas, close to where patients live and work.


Following a Different Model of Care

Accountable care organizations (ACOs) focus on improving the patients’ health and experience while reducing costs.


Prioritizing Women’s Heart Health at University Health System

University Health System is addressing a gap in health care for women who have or are at risk for heart disease.


Newborns Benefit From New Heart Screening Guidelines

Congenital heart disease (CHD) affects about 1 percent of newborn babies per year in the United States, and approximately one quarter of those will have critical congenital heart disease (CCHD) that requires catheter or surgical intervention during the first year. CHDs are a leading cause of birth defect-associated infant illness and death. Babies born with these conditions are living a longer and healthier life, thanks to advancement in cardiac care. Newborn pulse oximetry screening for critical congenital heart disease helps identify those at risk.


The Value of an Academic Medical Center

A conversation with William L. Henrich, MD, MACP, President and Professor of Medicine, UT Health San Antonio


Giving Babies a Better Chance at Life

The research efforts of Cynthia Blanco, MD, Medical Director of the Neonatal Nutrition & Bone Institute at University Health System and Professor of Neonatology at UT Health San Antonio, recently helped the medication Omegaven gain FDA approval. The medication, developed by German healthcare company Fresenius Kabi, helps save the lives of infants with parenteral nutrition-associated liver disease.


UT Health San Antonio: Advancing Cancer Care For San Antonio

On Sept. 5, 2018, the UT Health San Antonio MD Anderson Cancer Center hosted a roundtable discussion with esteemed cancer leaders from UT Health San Antonio and MD Anderson Cancer Center to talk about the impact of cancer in San Antonio and how collaboration in patient care and research is essential to improving not only the outcomes for patients, but how creating a streamlined system of care using proven protocols and processes can best support families and caregivers. These thought leaders and clinicians walked through the rising incidence of the disease in San Antonio. They also laid out plans for how their work together will positively impact patients and their families while focusing on overall cost or “value” of health care spend for this disease that strikes aging and Hispanic populations disproportionately.


Baptist Network for Cancer Care: Our Approach to a Patient’s Needs

The prevention and treatment of breast cancer is optimally achieved through a well orchestrated team approach. The Baptist Network for Cancer Care was created more than five years ago to provide Bexar County and South Texas with an efficient and compassionate model to prevent and treat breast cancer. As a result, our Breast Centers have garnered and maintained national recognition and certification of excellence through the National Accreditation Program for Breast Centers (NAPBC).


FDA Fast Tracks Skin Cancer Drug After Success That Began at the START Center

Immunotherapy is the new frontier in cancer treatment, and researchers at START are at the forefront. START is one of the largest Phase 1 clinical trial organizations in the world.